ReutersRoche joins race for obesity drugs with $2.7 billion Carmot dealDec 4, 2023Ludwig BurgerBy Ludwig Burgermore_vert
Financial TimesRoche to buy Carmot for up to $3.1bn as race for obesity drugs intensifiesDec 4, 2023Donato Paolo ManciniBy Donato Paolo Mancinimore_vert
CNBCRoche enters obesity market with Carmot takeover but drugs may not be available until 2030Dec 4, 2023more_vert